chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt experienced usual SE initially - was very fatigued w/ fever of 101 for 1.5 x days, HA, chills - those then resolved. On 5/22 she began having word finding difficulty, difficulty processing, vision deficits and has overall regressed back to where she was in 7/20 (immediately after brain surgery).  Pt feels that acutely worsened symptoms were due to recieving Shingrix vaccine.
numbness to the right of my face and body; numbness to the right of my face and body; This is a spontaneous report from a contactable consumer (patient). A 47-years-old female patient (non-pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), formulation: Solution for injection, Batch/Lot Number: EN5318 via an unspecified route of administration in left arm on 28Jan2021 02:45 as single dose for covid-19 immunization. The patient was 47-years-old at the time of vaccination. The patient was not pregnant. Patient relevant medical history included prior to the vaccine about a month ago experienced the numbness in face and in body and currently consulting a neurologist. The patient's concomitant medications were not reported. Patient haven't taken other vaccine in four weeks and no other medications in two weeks. Patient have no known allergies. Patient was not tested to covid prior to vaccination and not tested post vaccination. On30Jan2021 at 19:00 the patient experienced numbness to the right of her face and body. AE resulted in emergency room/department or urgent care. No treatment taken for resulted adverse events. Outcome of the event was recovering.  Information about Lot/Batch number is requested.  Follow-up (08Feb2021): This is a follow-up spontaneous report received in response to the mail trail sent regarding the confirmation below mentioned query. The response included: [Query]:  Dear Colleague, Please see attached which was submitted by you. Please kindly confirm the date you first aware of the info reported in the attached source, as this date was considered as PRD (Pfizer receipt date). This date provided as 01Feb2021 on the report, while the adverse event start date provided as 30Jan2021 [Response]: Yes, the adverse event occurred on 30Jan. Here's the lot #EN5318.  Follow-up attempts are completed. No further information is expected.
Case number PHEH2013US026644 is an initial spontaneous report received from a pharmacist on 30 DEC 2013. The case refers to a 12-year-old male patient. Past medical history and concomitant medication were not reported. He was vaccinated with FLUCELVAX (batch number: 006031A and expiry date: JUN 2014) intramuscularly at dose of 0.5 ml on 30 DEC 2013. No adverse event was reported following this administration error.  Following an internal review on 18 AUG 2014, a significant correction was done for the information received on 30 DEC 2013. The BPI labeling of the event "inappropriate age at vaccine administration " changed from listed to unlisted and added second indication as "adult product administered to child".
Information has been received from a health professional concerning an 85 year old female with atrial fibrillation, hypertension and osteoporosis who on 9/28/05 was vaccinated with an IM dose in the deltoid of Pneumococcal 23v polysaccharide vaccine (lot 650327/0792P). Concomitant therapy included warfarin sodium Coumadin for the treatment of atrial fibrillation. It was reported that the patient was seen in the physicians office on 9/29/05 since her shoulder to elbow, of the arm that received the injection, was red, swollen, warm to the touch, and painful. It was noted that the pt was not hospitalized and the event was not life threatening. No other information was provided. Additional information has been requested.
Father reported on 9/21/10 that pt. had a seizure the morning after she received vaccinations on 7/13/10. Father reported pt. had a stomach ache the evening of 7/13/10 and then on 7/14/10 pt. was at the breakfast table and became stiff and fell backwards. No injury noted by father. Denied fever. States she was fine afterwards. No further incidents.
Client called the Health Department on 01/05/2022 to report that she had a "big, bumpy rash"on her lower back, right side breast and right buttock. She reported that it was not itchy and she was feeling fine otherwise. The rash was continuing to get worse. Recommended that client be seen by a medical provider and requested that she get written approval from a medical provider prior to receiving her 2nd vaccine. Spoke to client again on 01/21/2022. She reports that she saw a provider and took some Zyrtec and Benadryl. At the time of our conversation on 01/21/2022, she reported the rash had not resolved.
I am very allergic.  I have had reactions in past to flu vaccine.  My allergist told me to take a Zyrtec in the morning and evening for 2 days before taking the Covid vaccine.  I did that and also took chlorpheniramine on the date I received the vaccine (I do not like Zyrtec.  it is too strong).   I had no immediate reaction;  I waited 40 minutes at the hospital and then went home.  3 hours later my throat became very scratchy and sore.  I took another chlorpheniramine pill and went to sleep for about 1 hour.  When I got up, the scratchiness had gone. About 3 years ago, after a regular flu shot, my throat became scratchy 45 min. after the shot.   My dr at the time said I should not get flu shots again.  Then he died.  My new dr was very big on the flu shot.  I did it in his office.  That time, the reaction occurred 20 min after the shot.  I did not get flu shots thereafter.  However, with the severity of the Covid  epidemic, I decided to get the Covid shot.  I spoke to my allergist, who told me to take Zyrtec in the morning and at night two days before the shot so I would have a lot of antihistamine in my system.  I did that.  I did not take it on the day of the shot because it is too strong.  On the day of the Covid shot I took chlorpheniramine. I was fine after the shot.  I only had the reaction 3 hours later.
Intermittent soreness in area of the vaccination, Moved arm in circular motions for relief.  Soreness completely gone after 24 hours.
Chest pain, abdominal pain, nausea, diarrhea, pain in bilateral shoulder girdles and upper thoracic back within a few hours after vaccine administered. Most of these symptoms were gone in less than 24 hours except for the pain in both shoulders and upper thoracic back has persisted and both shoulders especially the right shoulder persists. The areas are also tender to the touch. Injection ghivenb in the left deltoid area.
Information has been received from an office manager concerning a patient who on an unknown date, was vaccinated with PNEUMOVAX 23 (lot# not reported). Concomitant therapy include influenza virus vaccine (unspecified). Subsequently the patient experienced something like an anaphylactic response. Unspecified medical attention was sought. Additional information has been requested.
12/4/2022 I woke up after feeling perfectly normal. I had an achy pain in both shoulders and when I took a deep breath, the upper part of my chest had a catchy pain that I would not feel if I was not breathing deeply. I could not lie on one shoulder. I felt this was weird because I had not been exercising. I propped my head up and fell back asleep. The next few days it kept happening intermittently. I ran a temperature of 100.1 and felt achy. I took 2 extra strength TYLENOL and never had a fever again. Over the next few days, I continued to feel the aching in mostly my left shoulder and only had pain in my upper chest. On 12/7/22 in the afternoon it felt like the pain was escalating. I went to the urgent care. They listened to my heart and lungs and said it sounded good. I had an EKG and was told there was something a little concerning on it. I was sent by ambulance to the emergency room. They did a chest x-ray, EKG and did a heart enzyme test. They also did a COVID and flu test. Everything was negative and I was told there is nothing to indicate it is my heart. I was given a dose for TORADOL for the discomfort, and they sent me home. The TORADOL completely relieved the pain and I have not had it again. I still am feeling tired. I have not needed to take anything since the TYLENOL the first night and the TORADOL in the emergency room. For the last few days, I have been feeling much better.
Assessment: 1.  Suspect acute myopericarditis likely immune related/related to second dose of Covid vaccine. 2.  Troponin elevation likely due to acute myopericarditis.  This is a 30-year-old male with no previous cardiac history.  This past Thursday he got the second dose of Pfizer Covid vaccine.  He had the usual muscle aches at the site of the injection.  The next day he felt crappy, cold, etc.  Nevertheless he went to work.  This was Friday.  On Saturday he felt better.  He visited his grandma.  On the way to home he felt a little dizzy.  He took a meclizine when he got to the his grandmother's home.  He helped her eat, and then went home.  On Saturday night he started to feel cold and chilled.  His face felt li
STROKE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the patient experienced stroke. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210708514-Covid-19 vaccine ad26.cov2.s Stroke. This event(s) is considered unassessable. The event(s) has unknown temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Patient states that he has been feeling dizzy/vertigo. He is unsure if it is related to the flu vaccine, but has noticed it since it was administered. He is plannign to see md.
got shingles months after her vaccine, death/Suspected vaccination failure; Shingles led to her death, demise; Horrible pain; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria death and GSK medically significant), shingles (serious criteria death) and pain. On an unknown date, the outcome of the vaccination failure and shingles were fatal and the outcome of the pain was unknown. The reported cause of death was shingles and vaccination failure.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 04-MAR-2023 Reporter's Comment: This case was reported by a patient's child via interactive digital media. The reporter reported that the patient got shingles a couple months after her Shingles vaccine which led to her death a few months later. She had horrible pain. The reporter stated that he/she was done with these so-called vaccines that did not prevent disease but the CDC (Centers for Disease Control and Prevention) wants them to believe that there some unmeasurable best protection as his/her mother also received Shingles vaccine a few months before she was demise due to shingles. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.; Reported Cause(s) of Death: Shingles; Vaccination failure
loss of appetite; lowenergy; body aches; fatigue; low grade fever; This spontaneous case was reported by an other health care professional and describes the occurrence of DECREASED APPETITE (loss of appetite), ASTHENIA (lowenergy), PAIN (body aches), FATIGUE (fatigue) and PYREXIA (low grade fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included UTI. Concomitant products included AMOXICILLIN, CLAVULANIC ACID (AUGMENTIN [AMOXICILLIN;CLAVULANIC ACID]) for UTI.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced DECREASED APPETITE (loss of appetite), ASTHENIA (lowenergy), PAIN (body aches), FATIGUE (fatigue) and PYREXIA (low grade fever). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. On 07-Mar-2021, DECREASED APPETITE (loss of appetite), ASTHENIA (lowenergy), PAIN (body aches), FATIGUE (fatigue) and PYREXIA (low grade fever) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient's second dose is schedule on 31MAR2021
Red itchy rash on neck, arms and legs that appeared the day after the vaccine and have last for a few days
Information has been received from a registered nurse RN concerning a 12 year old female who on 09FEB2004 was vaccinated SC with a 0.5ml dose of varicella virus vaccine live. There was no concomitant therapy. The RN reported that on 01MAR2004, the patient developed a rash. Unspecified medical attention was sought, but no treatment or laboratory/diagnostics test were done. At the time of this report, the outcome was unknown.  The RN also reported that the pts sibling developed a fever after being vaccinated with varicella virus vaccine live. Additional info has been requested.
Patient received 1st dose COVID vaccine on 2/23/21. Presented at clinic for 2nd dose on 3/16/21. Reported "swollen glands that were achy in neck area and a sinus headache" after the first dose. Denied any rash, dyspnea, or other s/s allergic reaction or anaphylaxis. Clinic staff discussed with medical advisor before giving 2nd dose. Medical advisor recommended continuing with 2nd dose, as swelling was likely immune response and patient did not have any breathing difficulties. Patient agreeable and received 2nd dose.
Vaccine administered after more than 1 temperature excursion; dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021 at 11:21 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 28-Apr-2021 at 11:21 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 31.80.  No concomitant medications were reported.  The vial was initially stored in the fridge on 19-Apr-2021, moved to clinic on 28-Apr-2021 and proposed beyond use date was 19-May-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit.  On 27-Apr-2021, at 09:00 A.M., the temperature recorded was 35 degree Fahrenheit, that has been reached by the vial.  On 28-Apr-2021, at 09:00 A.M, the temperature recorded was 33 degree Fahrenheit, that has been reached by the vial.  Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour.  The vial was not in a frozen state at the time of vaccine administration.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  No treatment information was provided.   This case was linked to MOD-2022-566976 (Patient Link).
hitting head; falling; weakness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEAD INJURY (hitting head) and ASTHENIA (weakness) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no relevant medical history).    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced ASTHENIA (weakness) (seriousness criterion hospitalization). On 11-Mar-2021, the patient experienced HEAD INJURY (hitting head) (seriousness criterion hospitalization). The patient was hospitalized from 11-Mar-2021 to 22-Mar-2021 due to ASTHENIA, FALL and HEAD INJURY. On 22-Mar-2021, HEAD INJURY (hitting head) had resolved. At the time of the report, ASTHENIA (weakness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, SARS-CoV-2 test: positive (Positive) She also tested positive for covid-19 on 12Mar2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was transferred to nursing home after hospitalization (22Mar2021-30Mar2021). No concomitant medications were reported. 2nd dose of vaccine is scheduled for 22Apr2021.  Very limited information regarding these events has been provided at this time. The events are probably related to the patient's comorbidities.   This case was linked to MODERNATX, INC.-MOD-2021-069756 (E2B Linked Report).; Sender's Comments: Very limited information regarding these events has been provided at this time. The events are probably related to the patient's comorbidities MODERNATX, INC.-MOD-2021-069756:
This spontaneous report as received from a nurse practitioner refers to a 25 year old female patient. On an unspecified day in February of 2014 the patient was vaccinated with a dose of PNEUNOVAX23 (lot # H018441, expiration date: 28-FEB-2014), dose, frequency, route were unknown. On an unknown date in 2014 the patient experienced swelling at the injection site and a fever. The outcome of the events was reported as recovered/resolved on an unknown date in 2014. Additional information has been requested.
she has had serious problems with her feet and legs ever since; both of her feet and legs swelled up; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (she has had serious problems with her feet and legs ever since) and PERIPHERAL SWELLING (both of her feet and legs swelled up) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (she has had serious problems with her feet and legs ever since) and PERIPHERAL SWELLING (both of her feet and legs swelled up). At the time of the report, LIMB DISCOMFORT (she has had serious problems with her feet and legs ever since) and PERIPHERAL SWELLING (both of her feet and legs swelled up) outcome was unknown.            Concomitant medication were not provided. Treatment details were not provided.   This case was linked to MOD-2021-219904 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Correspondence email response attached no new information
Got the vaccine and experienced slight shortness of breath, and then started developing a bronchitis-type cough that was very severe, very persistent and could not speak due to the bronchial cough.  Her arm was not sore, no other symptoms other than the cough.  She took Nyquil that night to go to bed, and then in the morning she went to the UC on 3/2/21, and she was prescribed and prescribed a rescue inhaler Albuterol sulfate, which has helped her.  She does have an APT with her PCP tomorrow.  At the 24 hour mark from the vaccine is when she noticed improvement and had had 2 doses of the inhaler.   Did have a reaction to the flu vaccine in the past, and discussed this vaccine with the doctor who prescribed an Epi-Pen and told her to take Benadryl before the vaccine.
sick; nausea; chills; body aches; cold chills; with nausea persisting for "2 weeks" and being the most "prevalent"; This is a spontaneous report from a contactable consumer. A 44-years-old female patient received bnt162b2 (BNT162B2)Solution for injection, dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation.The patient medical history and concomitant was not reported. On unknown date, The patient experienced sick, nausea, body aches cold chills, with nausea persisting for "2 weeks" and being the most "prevalent" (condition aggravated) .The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Narrative:  83 yo male patient died during inpatient hospice admission on 12/17/2021. Death was caused by: Small Bowel Obstruction in the setting malignancy (stage IV bladder cancer). Pt. had received covid vaccines on 2/5/21 & 2/26/21. This death is not related to covid vaccines.
Patient felt dizzy and passed out. Then started convulsing for a moment. Patient was passed out for less than a minute then woke up.
Patient barely brought to our attention the reaction she had from the vaccination she had today, Sept 8th. But her initial reaction started the day after on Aug 26th ( 1 day after vaccination). She started to have redness, warmth, and very itchy. She didnt seek treatment until Friday September 30th. She had marked her arm and saw the redness spread to her elbow